Top Story

Bascom Palmer, Wills Eye top list of best ophthalmology hospitals

August 14, 2018

FDA issues complete response letter on Eylea 12-week dosing

August 14, 2018
The FDA has issued a complete response letter regarding Regeneron’s supplemental biologics license application for 12-week dosing of Eylea, the company announced…
Meeting News

7 Steps to improving your patient satisfaction, online reputation

August 14, 2018
AUSTIN, Texas — Speaking from lessons learned, one expert at GI Outlook walked through the importance of understanding online physician reputation and its…

Eyenovia’s piezo-print latanoprost microdose shows positive results

August 14, 2018
A proof-of-concept study of a microdose of latanoprost 0.005% showed positive results, according to a press release from Eyenovia. The EYN PG21 study evaluated 60 eyes…

ACP: CMS ‘Pathway to Success’ is a bumpy one

August 14, 2018
The American College of Physicians said in a press release there were good things and bad things about the new CMS plan known as Pathways to Success — a plan the…
More Headlines »
Original Article

Efficacy and Safety of Low-to-Moderate Dose Oral Corticosteroid Treatment in Ocular Myasthenia Gravis

Journal of Pediatric Ophthalmology and Strabismus
Online Advanced Release, August 3, 2018
To evaluate the response to corticosteroid therapy as a primary treatment for ocular myasthenia gravis. Patients…
More »

Preserving the Ocular Surface: Practice Pearls Part 3

This activity is supported by educational grants from Allergan, Inc.; Bausch + Lomb; and Shire.

Dry eye symptoms are experienced by many patients, especially with aging. Unfortunately, millions of patients with…
More »
Resource Centers
Meeting News

VIDEO: Stem cell-derived RPE under study in geographic atrophy patients

August 3, 2018
More »